Navigation Links
K-V Pharmaceutical Names Thomas McHugh Chief Financial Officer
Date:7/15/2010

ST. LOUIS, July 15 /PRNewswire-FirstCall/ -- K-V Pharmaceutical Company (NYSE:  KVa/KVb) announced today that Thomas S. McHugh has been appointed Chief Financial Officer, effective immediately.

Mr. McHugh joined K-V in January 2009 as Vice President of Finance and Corporate Controller.  He served as the company's Interim Chief Financial Officer from September 2009 until April 2010 and as the Chief Accounting Officer since February 2010.  He possesses over 20 years of financial management expertise in the areas of regulatory and government compliance, internal and external financial reporting, investor relations, mergers and acquisitions and global finance.  

Greg Divis, Interim Chief Executive Officer of K-V, stated, "Tom has played a key leadership role on our finance team at a time when sound management of our financial resources and return to compliance has never been more vital.  His assumption of the role of CFO will further strengthen our financial management and help K-V as we continue to prepare for the resumption of normal business operations. We believe that Tom will continue to make a positive impact going forward and look forward to his contributions."

Prior to joining K-V, Mr. McHugh was the Managing Director – Global and Corporate Controller with Bearing Point, Inc. from 2005 to 2008; Vice President of Finance, Chief Financial Officer, Treasurer and Chief Accounting Officer with Huttig Building Products, Inc. from 2000 to 2005; and Corporate Controller and Chief Accounting Officer with XTRA Corporation from 1993 to 2000.  Mr. McHugh began his professional career
'/>"/>

SOURCE K-V Pharmaceutical Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
8. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)...  The Partnership to Fight Chronic Disease (PFCD) released a public opinion ... a new study analyzing the impact of increased cost sharing on ... working to educate policy makers and the public on the costs ... on how the Iowa healthcare exchange could ...
(Date:1/23/2015)... and DUBLIN , Jan. 23, 2015 ... with KRS Global Biotechnology, Inc. for the compounding, packaging and ... for shipment in the United States . ... Outsourcing Facility capable of compounding naltrexone tablets in various strengths ...
(Date:1/23/2015)... Fla. , Jan. 23, 2015  iMD Companies, Inc. (ICBU) ... to increase market share and grab a foothold in the ... influence, production capabilities and a presence in the sector, and ... facilitate the growth of hemp and medical marijuana, iMD is ...
Breaking Medicine Technology:New research shows Iowa health exchange would benefit from improvements 2New research shows Iowa health exchange would benefit from improvements 3Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 2Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 3Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 4iMD Companies Poised to Make Impact in Multi-Billion Dollar Medical Marijuana Sector With Recent Investments and Strategic Partnerships 2
... already,face many challenges in treating patients with cancer, ... be quite difficult as studies,suggest that certain therapies ... a study prepublished today online in Blood, the ... women treated with,imatinib, a commonly used therapy for ...
... Ingredient in Core4Life Advanced Memory Formula(TM), PURCHASE, ... NXXI ), a developer and marketer of nutritional ... cardiovascular health,enhance memory and address chronic joint pain, ... showed daily supplementation with 1000 mcg of,chromium, as ...
Cached Medicine Technology:Leukemia Therapy With Imatinib During Pregnancy May Cause Infant Abnormalities 2Leukemia Therapy With Imatinib During Pregnancy May Cause Infant Abnormalities 3New Clinical Data Further Supports Chromium Picolinate's Role in Enhancing Brain Activity in Older Adults 2New Clinical Data Further Supports Chromium Picolinate's Role in Enhancing Brain Activity in Older Adults 3New Clinical Data Further Supports Chromium Picolinate's Role in Enhancing Brain Activity in Older Adults 4
(Date:1/22/2015)... Autocarinsurancebest.com has released a new blog post ... insurance policy . , Auto insurance quotes help many ... no longer necessary to call an agent or visit an ... on a single website: http://autocarinsurancebest.com/ . , Every business ...
(Date:1/22/2015)... Carinsurancesavings.biz has released a new blog post presenting ... . , Purchasing an accidental death and dismemberment rider ... type of rider provides benefits if the insured dies in ... lesser form of life insurance. , AD&D is not ...
(Date:1/22/2015)... NY (PRWEB) January 22, 2015 ... of Sports Medicine flagship journal Medicine & Science ... L-Citrulline before exercise may help reduce gastrointestinal (GI) ... 1 , Participants in the double-blind, placebo-controlled ...
(Date:1/22/2015)... Recently, Weddingshe.com has added many trendy Champagne ... highest annual revenues in the past three years. Today, the ... dresses. , According to the sales manager of the company, ... them in 2015. This point can be reflected on the ...
(Date:1/22/2015)... Boulder, Colorado (PRWEB) January 22, 2015 Four years ... is Queen – which coincided with the marriage of Avasa & ... album, THE ROAD, which is scheduled for release through White Swan ... heartfelt message that there is a sacred path available to all ...
Breaking Medicine News(10 mins):Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 4
... one of the country,s largest and most comprehensive academic medical ... ranked hospitals in the New York area, according to U.S. ... consecutive year that NewYork-Presbyterian has been listed on U.S. News, ... Hospitals 2010-11 ranks 152 medical centers nationwide in 16 specialties. ...
... By Steven Reinberg HealthDay Reporter , THURSDAY, July ... finds that almost 20 percent watch more than the recommended ... pretty generalizable to the rest of the country," said study ... the U.S. Centers for Disease Control and Prevention, working ...
... HealthDay Reporter , THURSDAY, July 15 (HealthDay News) -- For ... the risk of stroke increases, a small, preliminary study suggests. ... short time, the researchers noted that moderate drinking over the ... stroke. "The risk of ischemic stroke may be transiently ...
... Johnson Foundation, the nation,s largest philanthropy devoted exclusively to ... has chosen Dr. Paul Lipkin, Director of Kennedy Krieger ... coveted National Health Policy Fellowship. As America,s health ... the lives of millions are impacted by the nation,s ...
... team of scientists, led by researchers at the University of ... mutation responsible for a condition in which eye and brain ... suggest a potential remedy that would involve a simple, daily ... congenital disorders of glycosylation or CDG, a group of syndromes ...
... HealthDay Reporter , THURSDAY, July 15 (HealthDay News) ... male couples surveyed in the San Francisco area have differing ... some men at an unknowing risk of being infected with ... percent said they were monogamous and slightly more said they ...
Cached Medicine News:Health News:NewYork-Presbyterian No. 6 hospital in nation, No. 1 in NY 2Health News:NewYork-Presbyterian No. 6 hospital in nation, No. 1 in NY 3Health News:Too Many Tots Watching Too Much TV: Study 2Health News:Too Many Tots Watching Too Much TV: Study 3Health News: Stroke Risk May Rise First Hour After Drinking 2Health News: Stroke Risk May Rise First Hour After Drinking 3Health News:Kennedy Krieger Institute's Dr. Paul Lipkin selected for national health policy fellowship 2Health News:UC San Diego researchers find cause of metabolic disease -- and possible cure 2Health News:UC San Diego researchers find cause of metabolic disease -- and possible cure 3Health News:Gay Couples Vulnerable to HIV When Monogamy Is Unsure 2Health News:Gay Couples Vulnerable to HIV When Monogamy Is Unsure 3
The Unitrac Retraction System is a pneumatic device that provides absolute rigid retraction and stable positioning to the operating room, freeing the surgical assistant to carry out higher priority t...
... also known as BMP-7, is a member of ... Bone Morphogenetic Proteins. OP-1 Implant is known to ... mature skeletal systems. The FDA approved OP-1 Implant ... 2001. OP-1 Implant is now available across the ...
Cloward Dowel CL18 Used for Anterior Cervical Fusion and are preserved by Freeze-dried method....
... Connect allografts are dense corticocancellous ... cortical face providing structural integrity ... rapid healing. These allografts are ... designs. Connect allografts are processed ...
Medicine Products: